Inspire Medical Systems Inc. has published the transcript of its Fourth Quarter and Full Year 2025 earnings conference call, held on February 11, 2026. The event featured key company leaders including the Chairman and Chief Executive Officer, the Chief Financial Officer, and the Vice President of Investor Relations, alongside several prominent financial analysts from firms such as Piper Sandler, Stifel, JPMorgan, Bank of America Securities, Baird, Wells Fargo, Nephron Research, Mizuho Americas, KeyBanc Capital Markets, and Leerink Partners. During the call, management provided updates on the reimbursement process for the Inspire V System and reviewed the company’s financial results for both the fourth quarter and the full year 2025. The discussion also included the outlook for full year 2026. Management emphasized the strength of the Inspire V product, with one executive stating, “What drives us at Inspire is Inspire V is a rock-solid product. And we show the clinical evidence to it. We know the benefits that patients can have because we have clinical data both from Singapore as well as from our new product launch in the U.S.” Other topics addressed included the challenges faced by patients in accessing treatment and how the company is working with medical centers and physicians to manage patient flow. The full transcript can be accessed through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inspire Medical Systems Inc. published the original content used to generate this news brief on February 12, 2026, and is solely responsible for the information contained therein.